Free Trial

NanoViricides (NNVC) News Today

NanoViricides logo
$1.40 +0.05 (+3.70%)
As of 12:21 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
NanoViricides unaffected by US tariff turmoil, says CFO
Small cap headlines: EnWave, NanoViricides, GoviEx, TNR Gold
NanoViricides reports Q2 EPS (14c) vs. (18c) last year
NanoViricides pushes NV-387 to Phase II trials
NanoViricides prepares for Phase II trials for antiviral NV-387
Frontier Biotechnologies Inc. (688221.SS)
NanoViricides discusses lead program and next steps
Get NanoViricides News Delivered to You Automatically

Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.

NNVC Media Mentions By Week

NNVC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NNVC
News Sentiment

0.00

0.74

Average
Medical
News Sentiment

NNVC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NNVC Articles
This Week

0

1

NNVC Articles
Average Week

Get NanoViricides News Delivered to You Automatically

Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:NNVC) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners